HomeTagsChina

China

SGX-LISTED COMPANIES

Top Glove Q3 FY2026 Earnings Rise Despite Fluctuating Material Costs

Resilient Growth and Strategic Agility Top Glove Corporation has reported a remarkable 138% year-on-year surge...
Pharmaceutical

AstraZeneca invests US$20M to curb Malaysia chronic disease burden

AstraZeneca is scaling up early screening and clinical research efforts in Malaysia as the...
spot_img
SGX-LISTED COMPANIES

Why Hongkong Land’s S$541M Stake In Suntec REIT Is A Strategic Masterclass

Introduction: The Power of Strategic Recycling For the institutional allocator, the most sophisticated moves are...
SGX-LISTED COMPANIES

Why China Medical Systems FY2025 Profits Dropped Despite Growth

https://open.spotify.com/episode/3YAldvdzS4eXE4RzkN9M18?si=8a54594510534cfe 5 Game-Changing Takeaways from CMS’s 2025 Transformation For the Chinese pharmaceutical sector, 2025 was the...
SGX-LISTED COMPANIES

China Aviation Oil Dominates Jet Fuel Supply

https://open.spotify.com/episode/7DJ9PIClq14eEsV4ioIJ3Q?si=6cf2e704c16b42f0 5 Takeaways from China Aviation Oil’s Record Year While mainstream investors scramble to play the...
SGX-LISTED COMPANIES

5 Surprising Ways CapitaLand China Trust Is Reimagining The “New China” Economy In FY2025

Introduction The prevailing narrative surrounding China’s real estate sector remains one of caution, characterized by...
Logistics

DHL steps up investment in China ahead of APEC summit, in spite of tariffs

Overview: DHL Global Forwarding focuses on freight forwarding, handling large shipments via air, ocean, rail,...

Latest articles

SGX-LISTED COMPANIES

Top Glove Q3 FY2026 Earnings Rise Despite Fluctuating Material Costs

Resilient Growth and Strategic Agility Top Glove Corporation has reported a remarkable 138% year-on-year surge...
Pharmaceutical

AstraZeneca invests US$20M to curb Malaysia chronic disease burden

AstraZeneca is scaling up early screening and clinical research efforts in Malaysia as the...
Pharmaceutical

AstraZeneca expands diagnostics and AI to tackle late-stage cancer deaths

AstraZeneca is sharpening its long-term AstraZeneca cancer strategy with a combination of heavy research...
Pharmaceutical

AstraZeneca deploys AI to cut drug timelines by 30% and boost survival

AstraZeneca is stepping up its investment in AI drug discovery to shorten treatment timelines...